A
Anuranjan
About Anuranjan
Data last updated:
Anuranjan is a Director at Baxter Pharmaceuticals India Private Limited (since 2024), Director at Baxter Pharmaceuticals India Private Limited (since 2024) and Director at Baxter India Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Construction. The 4 current companies with reported revenue have a combined latest revenue of ₹1,852 Cr; the largest is Baxter Pharmaceuticals India Private Limited at ₹672 Cr (FY 2025). Earlier, Anuranjan was a Director at Accession Buildwell Private Limited (2010) and Director at Toff Builders Private Limited (2010–2011) and 18 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Oct 2024 | 2005 | ₹672 Cr (FY 2025) | Active | |
| Director | 01 Oct 2024 | 2005 | ₹672 Cr (FY 2025) | Active | |
| Director | 22 Jul 2025 | 1996 | ₹505 Cr (FY 2024) | Active | |
| Director | 31 Jan 2025 | 2013 | ₹3.54 Cr (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jan 2010 | 2006 | ₹80.5 Lakh (FY 2016) | Active | |
| Director | 16 Aug 2010 | 2006 | Active | ||
| Director | 16 Aug 2010 | 2006 | ₹6,438 (FY 2025) | Active | |
| Director | 16 Aug 2010 | 2006 | Active | ||
| Director | 16 Jan 2010 | 2007 | Active | ||
| Director | 16 Aug 2010 | 2006 | ₹1.5 Lakh (FY 2016) | Active | |
| Director | 16 Jan 2010 | 2007 | ₹29,300 (FY 2025) | Active | |
| Director | 16 Jan 2010 | 2007 | ₹2.24 Cr (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anuranjan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anuranjan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anuranjan
Anuranjan currently holds 4 directorships: Baxter Pharmaceuticals India Private Limited (Director, since 01 Oct 2024, revenue ₹672 Cr (FY 2025)); Baxter Pharmaceuticals India Private Limited (Director, since 01 Oct 2024, revenue ₹672 Cr (FY 2025)); Baxter India Private Limited (Director, since 22 Jul 2025, revenue ₹505 Cr (FY 2024)); Hill-Rom India Private Limited (Director, since 31 Jan 2025, revenue ₹3.54 Cr (FY 2026)).
Anuranjan was first appointed on 16 Jan 2010 as Director at Accession Buildwell Private Limited. The most recent appointment on record is 22 Jul 2025 at Baxter India Private Limited.
The 4 current companies of Anuranjan that report revenue have a combined latest revenue of ₹1,852 Cr: Baxter Pharmaceuticals India Private Limited ₹672 Cr (FY 2025); Baxter Pharmaceuticals India Private Limited ₹672 Cr (FY 2025); Baxter India Private Limited ₹505 Cr (FY 2024); Hill-Rom India Private Limited ₹3.54 Cr (FY 2026).
Anuranjan held 20 earlier board appointments: Accession Buildwell Private Limited (Director, 16 Jan 2010 to 02 Jul 2010); Toff Builders Private Limited (Director, 16 Aug 2010 to 21 Mar 2011); Trattoria Properties Private Limited (Director, 16 Aug 2010 to 21 Mar 2011); Tome Builders Private Limited (Director, 16 Aug 2010 to 21 Mar 2011); Elite Conbuild Private Limited (Director, 16 Jan 2010 to 21 Mar 2011); and 15 more.
The current boards of Anuranjan's companies include Anurag Bharatkumar Pachchigar (Baxter Pharmaceuticals India Private Limited), Ashwin Prakash Upasane (Baxter Pharmaceuticals India Private Limited), Gurjeet Singh Bedi (Baxter Pharmaceuticals India Private Limited), Sanju Dhawan (Baxter Pharmaceuticals India Private Limited), Tripti Sapra (Baxter Pharmaceuticals India Private Limited), Ajay Bijani (Baxter India Private Limited), among others.